BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.69B |
| 2 |
Apple
AAPL
|
+$892M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$799M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$793M |
| 5 |
GE Aerospace
GE
|
+$748M |
Top Sells
| 1 |
Tesla
TSLA
|
+$362M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$345M |
| 3 |
NVIDIA
NVDA
|
+$258M |
| 4 |
MetLife
MET
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| 1 | Technology | 26.74% |
| 2 | Consumer Discretionary | 11.23% |
| 3 | Financials | 10.63% |
| 4 | Healthcare | 8.41% |
| 5 | Communication Services | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1751
SI-BONE Inc
SIBN
$653M
| $1.44M | ﹤0.01% |
102,556
-3,886
| -4% | -$54.5K |
|
1752
Petco
WOOF
$972M
| $1.43M | ﹤0.01% |
+374,842
| New | +$1.43M |
|
1753
ADC Therapeutics
ADCT
$360M
| $1.43M | ﹤0.01% |
+716,668
| New | +$1.43M |
|
1754
Kura Oncology
KURA
$713M
| $1.42M | ﹤0.01% |
163,559
+148,272
| +970% | +$1.29M |
|
1755
Veritex Holdings
VBTX
$1.87B
| $1.42M | ﹤0.01% |
52,423
-4,136
| -7% | -$112K |
|
1756
Ardelyx
ARDX
$1.57B
| $1.42M | ﹤0.01% |
280,269
+98,882
| +55% | +$501K |
|
1757
US Physical Therapy
USPH
$1.21B
| $1.42M | ﹤0.01% |
16,003
-839
| -5% | -$74.4K |
|
1758
ACM Research
ACMR
$1.91B
| $1.42M | ﹤0.01% |
93,861
+55,612
| +145% | +$840K |
|
1759
National Beverage
FIZZ
$3.62B
| $1.41M | ﹤0.01% |
33,092
+17,494
| +112% | +$746K |
|
1760
Live Oak Bancshares
LOB
$1.67B
| $1.41M | ﹤0.01% |
35,649
+10,595
| +42% | +$419K |
|
1761
LXP Industrial Trust
LXP
$2.71B
| $1.41M | ﹤0.01% |
173,238
-26,374
| -13% | -$214K |
|
1762
SoundHound AI
SOUN
$5.79B
| $1.4M | ﹤0.01% |
+70,799
| New | +$1.4M |
|
1763
Amalgamated Financial
AMAL
$849M
| $1.4M | ﹤0.01% |
+41,886
| New | +$1.4M |
|
1764
OFG Bancorp
OFG
$1.94B
| $1.4M | ﹤0.01% |
33,107
-2,195
| -6% | -$92.9K |
|
1765
Cullinan Oncology
CGEM
$375M
| $1.4M | ﹤0.01% |
+115,000
| New | +$1.4M |
|
1766
Novanta
NOVT
$4.09B
| $1.4M | ﹤0.01% |
9,159
-10,895
| -54% | -$1.66M |
|
|
PENG
1767
Penguin Solutions, Inc. Ordinary Shares
PENG
$1.37B
| $1.4M | ﹤0.01% |
72,731
+43,156
| +146% | +$828K |
|
|
SUM
1768
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $1.4M | ﹤0.01% |
27,579
-3,152
| -10% | -$159K |
|
1769
Coca-Cola Consolidated
COKE
$10.6B
| $1.39M | ﹤0.01% |
11,050
-3,690
| -25% | -$465K |
|
1770
Global Industrial
GIC
$1.42B
| $1.39M | ﹤0.01% |
+56,131
| New | +$1.39M |
|
1771
Napco Security Technologies
NSSC
$1.56B
| $1.39M | ﹤0.01% |
38,963
-81,632
| -68% | -$2.9M |
|
1772
CareDx
CDNA
$746M
| $1.37M | ﹤0.01% |
64,141
+14,721
| +30% | +$315K |
|
1773
Amphastar Pharmaceuticals
AMPH
$1.27B
| $1.37M | ﹤0.01% |
36,964
-57,502
| -61% | -$2.14M |
|
1774
First Bancorp
FBP
$3.47B
| $1.37M | ﹤0.01% |
73,781
-469
| -0.6% | -$8.72K |
|
1775
Global Partners
GLP
$1.71B
| $1.37M | ﹤0.01% |
29,332
-47,930
| -62% | -$2.23M |
|